MonoFer® (Iron Isomaltoside)
Monofer® is used for treating iron deficiency with and without anaemia when oral iron preparations are ineffective or cannot be used or when there is a need to deliver iron rapidly.
Approved in more than 36 countries globally with more than 10 million doses administered*
*based on Pharmacosmos A/S data on file, Dec 2017 (based on the WHO defined daily dose of 100mg and including doses of iron isomoltoside under all applicable trade names)
Good safety profile
- No dose dependency of ADRs
- Low level of labile iron
Convenient
- Meeting patient iron needs in just one visit
- Single dose up to 20mg/kg - no other dose limits
- No test dose required
Cost-effective
- Fewer patient visits
- Reduces waiting lists
- Frees up treatment capacity
Designed for treatment of ID across multiple therapeutic areas
- Nephrology
- Gastroenterology
- Obstetrics / Gynaecology
- Surgery
- Haematology
- Oncology
- Cardiology